Clinical Trial Update: Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine and capecitabine with or without T-ChOS as adjuvant therapy for patients with resected pancreatic cancer has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)
• T-ChOS

Snippet

Sponsor: Herlev Hospital | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED